Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value:
$4.94B
Total Bought:
$1.56B
Total Sold:
$341.38M
Net Transaction:
+$1.22B
Notable People:
Sarah Elizabeth Monime
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)20,457,44520,933,277+475,832$2.90B$3.64B73.78%+$746.48M
Belite Bio, IncADS(BLTE)03,027,704+3,027,704$0$486.92M9.86%+$486.92M
ABIVAX Société AnonymeADS(ABVX)3,164,5013,178,501+14,000$263.70M$439.71M8.90%+$176.02M
Cidara Therapeutics Inc997,196997,1960$94.99M$220.18M4.46%+$125.19M
Wave Life Sciences, Inc.SHS(WVE)07,298,421+7,298,421$0$125.17M2.53%+$125.17M
Capricor Therapeutics, Inc.(CAPR)0800,000+800,000$0$23.17M0.47%+$23.17M
uniQure N.V.SHS(QURE)400,0000-400,000$23.76M$0—-$23.76M
United Therapeutics Corporation(UTHR)748,5500-748,550$317.62M$0—-$317.62M
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q4 2025 | TickerTrail